Market Overview

Omnicell Sees Q4 Adj. EPS $0.49 to $0.55 vs $0.52 Est., Sales $201M to $207M vs $209M Est.


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: Guidance


Related Articles (OMCL)

Vetr Upgrades First Solar As Company Posts Strong Q3

A Look At Opiant Pharmaceuticals, The Stock That Skyrocketed On Trump's Opioid Declaration